Author Profile

Written By

Andrew McKay

Regional Market Manager

Latest Content from Andrew McKay

June 27, 2018

Forgotten research provides a new line of attack in the war on superbugs

While research into new antimicrobials can produce successful novel therapies, the process of getting a new drug to market is too slow to keep ahead of ever-evolving superbugs. To address this challenge, innovative organizations are rediscovering antibiotics of the past, and with the help of modern techniques and technology, are developing new weapons in the war on antimicrobial resistance.